IFN-gamma controls the generation/activation of CD4+ CD25+ regulatory T cells in antitumor immune response
- PMID: 16177085
- DOI: 10.4049/jimmunol.175.7.4433
IFN-gamma controls the generation/activation of CD4+ CD25+ regulatory T cells in antitumor immune response
Abstract
Immunization with serological identification of Ags by recombinant expression cloning (SEREX)-defined self-Ags leads to generation/activation of CD4+ CD25+ regulatory T cells with suppressive activities and enhanced expression of Foxp3. This is associated with increased susceptibility to pulmonary metastasis following challenge with syngeneic tumor cells and enhanced development of 3-methylcholanthrene-induced primary tumors. In contrast, coimmunization with the same SEREX-defined self-Ags mixed with a CTL epitope results in augmented CTL activity and heightened resistance to pulmonary metastasis, both of which depend on CD4+ Th cells. These active regulatory T cells and Th cells were derived from two distinct CD4+ T cell subsets, CD4+ CD25+ T cells and CD4+ CD25- T cells, respectively. In the present study, IFN-gamma was found to abrogate the generation/activation of CD4+ CD25+ regulatory T cells by immunization with SEREX-defined self-Ag. CD4+ CD25+ T cells from these IFN-gamma-treated mice failed to exhibit immunosuppressive activity as measured by 1) increased number of pulmonary metastasis, 2) enhanced development of 3-methylcholanthrene-induced primary tumors, 3) suppression of peptide-specific T cell proliferation, and 4) enhanced expression of Foxp3. The important role of IFN-gamma produced by CD8+ T cells was shown in experiments demonstrating that CD4+ CD25+ T cells cotransferred with CD8+ T cells from IFN-gamma(-/-) mice, but not from wild-type BALB/c mice, became immunosuppressive and enhanced pulmonary metastasis when recipient animals were subsequently immunized with a SEREX-defined self-Ag and a CTL epitope. These findings support the idea that IFN-gamma regulates the generation/activation of CD4+ CD25+ regulatory T cells.
Similar articles
-
CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination.J Immunol. 2003 Dec 1;171(11):5931-9. doi: 10.4049/jimmunol.171.11.5931. J Immunol. 2003. PMID: 14634104
-
Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.J Immunol. 1999 Nov 15;163(10):5211-8. J Immunol. 1999. PMID: 10553041
-
Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.J Immunol. 2004 Feb 1;172(3):1380-90. doi: 10.4049/jimmunol.172.3.1380. J Immunol. 2004. PMID: 14734713
-
The generation and antigen-specificity of CD4+CD25+ regulatory T cells.Inflamm Allergy Drug Targets. 2006 Sep;5(3):149-56. doi: 10.2174/187152806778256070. Inflamm Allergy Drug Targets. 2006. PMID: 16918478 Review.
-
Murine leukemia RL male 1 and sarcoma Meth A antigens recognized by cytotoxic T lymphocytes (CTL).Cancer Sci. 2003 Nov;94(11):931-6. doi: 10.1111/j.1349-7006.2003.tb01380.x. Cancer Sci. 2003. PMID: 14611667 Free PMC article. Review.
Cited by
-
The role of STAT3 in leading the crosstalk between human cancers and the immune system.Cancer Lett. 2018 Feb 28;415:117-128. doi: 10.1016/j.canlet.2017.12.003. Epub 2017 Dec 6. Cancer Lett. 2018. PMID: 29222039 Free PMC article. Review.
-
T regulatory cells: aid or hindrance in the clearance of disease?J Cell Mol Med. 2007 Nov-Dec;11(6):1291-325. doi: 10.1111/j.1582-4934.2007.00087.x. J Cell Mol Med. 2007. PMID: 18205702 Free PMC article. Review.
-
Immune biomarkers of anti-EGFR monoclonal antibody therapy.Ann Oncol. 2015 Jan;26(1):40-47. doi: 10.1093/annonc/mdu156. Epub 2014 Jul 4. Ann Oncol. 2015. PMID: 24997207 Free PMC article. Review.
-
Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity.Cancers (Basel). 2019 Dec 19;12(1):24. doi: 10.3390/cancers12010024. Cancers (Basel). 2019. PMID: 31861720 Free PMC article. Review.
-
Interleukin 12 stimulates IFN-gamma-mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance.Cancer Res. 2009 Nov 15;69(22):8700-9. doi: 10.1158/0008-5472.CAN-09-1145. Epub 2009 Oct 20. Cancer Res. 2009. PMID: 19843867 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials